Highlight selection of radiochemistry and radiopharmacy developments by editorial board - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles European Association of Nuclear Medicine, issuing body - EJNMMI radiopharmacy and chemistry Year : 2021

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Oliver C Neels
  • Function : Author
  • PersonId : 1109629
Wiktor Szymanski

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. Conclusions: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Domains

Cancer
Fichier principal
Vignette du fichier
FaivreChauvet2021Eq13.pdf (1.37 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-03338402 , version 1 (08-09-2021)

Identifiers

Cite

Francisco Alves, Inês F Antunes, Emiliano Cazzola, Frederik Cleeren, Bart Cornelissen, et al.. Highlight selection of radiochemistry and radiopharmacy developments by editorial board. European Association of Nuclear Medicine, issuing body - EJNMMI radiopharmacy and chemistry, 2021, 6, pp.31. ⟨10.1186/s41181-021-00146-9⟩. ⟨inserm-03338402⟩
37 View
37 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More